Women with pulmonary embolism (PE) who undergo percutaneous pulmonary artery thrombectomy have higher rates of morbidity and in-hospital mortality than men, a large, nationwide cohort study indicated.

New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot ...

VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using ...

There are several closely watched randomized trials examining catheter-directed therapies for acute pulmonary embolism, according to Parth Rali, MD, an associate professor of thoracic medicine and ...

Chest pain after a pulmonary embolism is common and may last days or even weeks. In most cases, symptoms improve as the clot dissolves, but some people can develop chronic pain. This pain typically ...

Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results ...

New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black people were less frequently treated with minimally invasive therapy compared ...

After experiencing a steady drop throughout the first decade of this century, the death rate from pulmonary embolism—in which a blood clot travels to the lungs and blocks blood flow—is back on the ...

A current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best chances of survival in high-risk acute pulmonary embolism. The results, now ...

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being. This Collection invites original research considering diagnostic criteria, prognosis evaluation, and ...

Researchers say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients. A new study finds that 51 percent of patients found to have a ...